Erlotinib, the active ingredient in Erlozest 150mg Tablet, is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). It is used to treat non-small cell lung cancer (NSCLC) and, in combination with gemcitabine, pancreatic cancer. Erlotinib works by inhibiting the EGFR pathway, thereby preventing cancer cell proliferation
Erlotinib Tablets I.P. 150 mg Erlozest 3x10 Tablets
$37.00 Regular Price
$25.90Sale Price
No Reviews YetShare your thoughts.
Be the first to leave a review.
